WATSON 395 50 0 .5 (Naloxone and Pentazocine 0.5 mg / 50 mg)
Pill imprint WATSON 395 50 0 .5 has been identified as Naloxone hydrochloride and pentazocine hydrochloride 0.5 mg / 50 mg.
Naloxone/pentazocine is used in the treatment of chronic pain; pain and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Naloxone/pentazocine 0.5 mg / 50 mg has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.
See also related documents.
Images for WATSON 395 50 0 .5
395 50 0 .5
- 0.5 mg / 50 mg
- 2.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Narcotic analgesic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 4 - Some potential for abuse
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
calcium phosphate dibasic anhydrous
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Yellow No. 6
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|66267-0487||Nucare Pharmaceuticals Inc (repackager)|
|55045-3099||Dispensing Solutions Inc. (repackager)|
|63874-0220||Altura Pharmaceuticals Inc (repackager)|
|68115-0462||Dispensexpress Inc (repackager)|
|23490-6073||Palmetto State Pharmaceuticals Inc (repackager)|
|43063-0142||PDRX Pharmaceuticals Inc (repackager)|
|35356-0176||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.
More about naloxone/pentazocine
- Other brands: Talwin Nx
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.